MRMDMARIMED INC.同业对比
MARIMED INC. 与Medicinal Chemicals & Botanical Products的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Medicinal Chemicals & Botanical Products)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRMD本股 | — | — | — | — | 1.3%#6 | -16.2%#9 | -1.8%#2 | -17.5%#2 | -1.7%#2 | 3#3 | — | — |
| GLUC | — | — | — | — | — | -54.3%#11 | — | — | — | — | — | — |
| HYEX | — | — | — | — | 44.9%#2 | 0.7%#8 | -73.7%#5 | -1.5%#1 | — | — | — | — |
| IMCC | $18M#4 | — | — | — | — | — | — | — | — | — | -94.8%#4 | — |
| JUSH | — | — | — | — | 2.1%#5 | -40.6%#10 | 1.8%#1 | — | 8.8%#1 | 3#3 | — | — |
| LEEEF | — | — | — | — | 22.1%#3 | 28.4%#2 | -21.8%#4 | — | — | — | — | — |
| MDWD | $171M#3 | — | — | 10.1x#1 | -16.1%#8 | 21.0%#3 | -149.0%#6 | — | — | — | -21.8%#1 | — |
| NPHC | — | — | — | — | 4.6%#4 | -59.2%#12 | -567.7%#9 | — | — | 2#6 | — | — |
| NTRR | — | — | — | — | -26.1%#9 | 11.3%#7 | -437.8%#8 | — | — | 3#3 | — | — |
| PLSH | — | — | — | — | 46.6%#1 | 12.3%#6 | -232.5%#7 | — | — | 4#1 | — | — |
| RAJAF | — | — | — | — | -0.6%#7 | 31.6%#1 | -11.3%#3 | — | — | 4#1 | — | — |
| RAPH | — | — | — | — | — | 15.8%#5 | — | — | — | — | — | — |
| RGC | $2.9B#1 | — | 598.2x#1 | — | — | 16.7%#4 | — | -73.7%#3 | -261.2%#3 | — | -61.9%#3 | — |
| SNDL | $362M#2 | — | — | — | — | — | — | — | — | — | -44.7%#2 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-09-22。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议